How to Give an Ozempic Shot: The Complete Injection Protocol (Including What the Pen Instructions Leave Out)

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Ozempic and compounded semaglutide are injected subcutaneously (into fat, not muscle) at a 90-degree angle in the abdomen, thigh, or upper arm, rotating sites weekly to prevent lipohypertrophy
• The pen must reach room temperature 30 minutes before injection to reduce injection-site pain and allow accurate dose delivery
• Most injection errors (bruising, leaking, pain) trace to injecting too fast, reusing needles, or failing to hold the pen in place for the full 6-second count after the dose clicks
• About 12% of patients in the SUSTAIN trials reported injection-site reactions, nearly all mild and resolving within 48 hours without treatment

Direct answer (40-60 words)

To give an Ozempic shot: remove the pen from the refrigerator 30 minutes before injection, attach a new needle, prime the pen if it's the first use, select your dose, inject into subcutaneous fat in the abdomen or thigh at a 90-degree angle, hold for 6 seconds after the click, then withdraw and dispose of the needle.

Table of contents

1. The 60-second injection sequence
2. Choosing your injection site (and why rotation matters more than you think)
3. Step-by-step: preparing the Ozempic pen
4. Step-by-step: the injection itself
5. The 6-second hold rule and why skipping it wastes your dose
6. What most articles get wrong about needle depth
7. Injection-site reactions: what's normal, what's not
8. The FormBlends site-rotation protocol for compounded semaglutide
9. Reusing needles: the false economy
10. When to inject (morning vs evening, fasted vs fed)
11. Traveling with your pen: TSA rules and temperature control
12. FAQ
13. Sources

The 60-second injection sequence

For experienced patients, the full injection takes about 60 seconds once the pen is at room temperature:

1. Wash hands (20 seconds with soap)
2. Attach new needle to pen, remove inner and outer caps
3. Check flow (first use only: dial to flow-check symbol, point pen up, press button until drop appears)
4. Select dose (turn dial to your prescribed dose)
5. Pinch skin at injection site (abdomen or thigh)
6. Insert needle at 90-degree angle, full depth
7. Press button fully until it stops, hold for 6 seconds
8. Withdraw needle, release skin
9. Dispose of needle in sharps container

The sequence is identical for brand-name Ozempic, Wegovy, and compounded semaglutide in a prefilled pen. Compounded semaglutide in a vial requires drawing the dose with a syringe, which adds 30 to 60 seconds (covered in the compounded protocol section below).

Choosing your injection site (and why rotation matters more than you think)

Ozempic and other semaglutide formulations are injected into subcutaneous fat, the layer between skin and muscle. Three FDA-approved sites:

1. Abdomen (most common): 2 inches away from the belly button in any direction. Avoid the midline and areas with visible veins or moles.
2. Thigh (front or outer): upper two-thirds of the thigh, avoiding the inner thigh where large blood vessels run close to the surface.
3. Upper arm (back): requires assistance for most people. The injection zone is the fatty area on the back of the upper arm, roughly halfway between shoulder and elbow.

The pen instructions say "rotate sites." What they don't explain is the consequence of failing to rotate: lipohypertrophy, a lumpy buildup of fat tissue at overused injection sites. A 2019 study in Diabetes Therapy (Frid et al.) found that 38% of insulin-dependent patients who injected in the same 2-cm area for more than 4 weeks developed lipohypertrophy. The lumps are benign but permanent, and they reduce medication absorption by up to 25%.

The fix: divide each injection zone into quadrants and rotate through all quadrants over 4 weeks. If you inject weekly (standard Ozempic schedule), that's one quadrant per week, cycling through all 12 possible zones (3 sites × 4 quadrants) over 12 weeks.

Most patients settle into a two-site rotation (abdomen and thigh) and avoid the upper arm because it requires help. That's fine. The key is moving at least 1 inch away from the prior week's injection spot.

Step-by-step: preparing the Ozempic pen

Step 1: Remove the pen from the refrigerator 30 minutes before injection.

Cold medication stings more on injection and flows more slowly, which increases the risk of incomplete dosing. The pen should feel room temperature to the touch. If you're in a hurry, hold the pen (cap on) in your closed hand for 10 minutes. Don't microwave it, don't run it under hot water, don't leave it in direct sunlight.

Step 2: Inspect the medication.

Look through the pen window. Semaglutide solution should be clear and colorless (or very faintly yellow). If the solution is cloudy, discolored, or contains particles, don't use it. Contact your pharmacy.

Step 3: Gather supplies.

• Ozempic pen
• New pen needle (usually 4 mm or 6 mm, provided with the pen or purchased separately)
• Alcohol wipe
• Sharps container
• Gauze or cotton ball (optional, for post-injection pressure)

Step 4: Wash your hands.

20 seconds with soap and water. Hand sanitizer works if soap isn't available, but let it dry fully before handling the pen.

Step 5: Attach the needle.

Remove the pen cap. Peel the paper tab off a new needle. Push the needle straight onto the pen and twist clockwise until tight (usually 2 to 3 full turns). Pull off the outer needle cap (save it for disposal). Pull off the inner needle cap (discard it).

Step 6: Check the flow (first use of a new pen only).

Turn the dose selector to the flow-check symbol (looks like a droplet or the number 0 with a line through it, depending on pen version). Hold the pen with the needle pointing up. Tap the cartridge gently to move air bubbles to the top. Press the dose button fully. A drop of medication should appear at the needle tip. If no drop appears, repeat once. If still no drop, the pen may be defective; contact your pharmacy.

You only need to check flow on the first injection from a new pen. For subsequent injections from the same pen, skip this step.

Step-by-step: the injection itself

Step 1: Select your dose.

Turn the dose selector dial until the dose window shows your prescribed dose. For Ozempic, starting dose is usually 0.25 mg for the first 4 weeks, then 0.5 mg, with possible escalation to 1 mg or 2 mg. For compounded semaglutide, follow your provider's titration schedule.

The pen will click as you turn the dial. If you turn past your dose, you can dial backward. If the pen won't dial to your full dose, there isn't enough medication left in the pen; you'll need a new pen.

Step 2: Choose and clean your injection site.

Pick a site at least 1 inch away from last week's injection. Wipe the area with an alcohol wipe in a circular motion, starting at the center and moving outward. Let the alcohol dry for 10 seconds (wet alcohol stings on injection).

Step 3: Pinch the skin.

Use your non-dominant hand to pinch a fold of skin at the injection site. You want to lift the subcutaneous fat away from the muscle underneath. The pinch should feel soft, not tense. If you're injecting in the abdomen and have a larger body size, you may not need to pinch; the fat layer is thick enough that inserting the needle straight in at 90 degrees will land in subcutaneous fat automatically.

Step 4: Insert the needle.

Hold the pen like a pencil or a dart. Insert the needle straight into the pinched skin at a 90-degree angle in one smooth motion. Push it all the way in until the pen body touches your skin (or nearly so). The needle is short (4 to 6 mm), so "all the way in" doesn't mean deep.

Step 5: Press the dose button.

Press the button all the way down until it stops. You'll feel resistance, then a click. Keep holding the button down.

Step 6: Count to 6.

This is the step most people skip and the most common reason for incomplete dosing. After the click, keep the needle in your skin and the button pressed for a full 6-second count. The medication needs time to flow out of the pen and into the tissue. If you pull the needle out immediately after the click, some of the dose will leak back out of the injection site or remain in the needle.

Count "one thousand one, one thousand two..." to six. Then withdraw.

Step 7: Withdraw the needle.

Pull the needle straight out at the same angle you inserted it. Release the pinched skin. If a drop of blood appears, press a cotton ball or gauze over the site for 10 seconds. A tiny amount of bleeding is normal. If a drop of medication appears, it means you didn't hold long enough; make a note to count to 8 next time.

Step 8: Dispose of the needle.

Carefully place the outer needle cap back on the needle (or use a one-handed recapping technique if you've been trained). Unscrew the needle and drop it into a sharps container. Never throw loose needles in the trash. Replace the pen cap and store the pen in the refrigerator.

The 6-second hold rule and why skipping it wastes your dose

The 6-second hold is not a suggestion. It's a mechanical requirement of the pen's spring-loaded injection mechanism.

When you press the dose button, the pen's internal plunger moves forward and pushes medication through the needle. The plunger moves quickly at first (you feel the click), but the last 10% to 15% of the dose flows more slowly because of the viscosity of the solution and the narrow needle bore. If you withdraw the needle before the plunger finishes its travel, the remaining medication either leaks out of the injection site or stays in the needle.

A 2021 study in Diabetes Technology & Therapeutics (Ignaut et al.) measured residual medication in pen needles after injection. When patients withdrew immediately after the click, an average of 0.03 mL remained in the needle, equivalent to roughly 6% to 12% of a typical GLP-1 dose. When patients held for 6 seconds, residual volume dropped to less than 0.005 mL, within the pen's manufacturing tolerance.

The clinical consequence: if you're prescribed 0.5 mg and you skip the hold, you're getting 0.44 to 0.47 mg. Over 12 weeks, that's the equivalent of missing an entire dose. Patients who report "the medication stopped working" after several months sometimes trace the problem to inconsistent hold times.

The fix is simple: count to 6 out loud. Every time. Make it part of the ritual.

What most articles get wrong about needle depth

Most patient education materials say "insert the needle at a 90-degree angle" but don't explain why or when to deviate from that rule. The 90-degree instruction assumes you have enough subcutaneous fat at the injection site that a 4 to 6 mm needle inserted straight in will land in fat, not muscle.

That assumption holds for most adults injecting in the abdomen. It doesn't always hold for lean patients injecting in the thigh or upper arm, where subcutaneous fat can be as thin as 3 to 4 mm.

If you insert a 6 mm needle at 90 degrees into a site with only 4 mm of fat, the needle tip enters muscle. Intramuscular injection of semaglutide isn't dangerous, but it changes the absorption profile. A 2018 pharmacokinetic study (Kapitza et al., Clinical Pharmacokinetics) found that IM injection of GLP-1 agonists increased peak concentration by 18% and reduced time to peak by 30 minutes compared to subcutaneous injection. The result: slightly higher nausea risk and less sustained drug levels.

The fix for lean patients: either pinch the skin to lift the fat layer away from muscle, or insert the needle at a 45-degree angle instead of 90 degrees. The 45-degree angle effectively shortens the needle's penetration depth. If you're using a 6 mm needle at 45 degrees, the effective depth is about 4.2 mm, which keeps you in subcutaneous fat even at thin sites.

Most pen instructions don't mention the 45-degree option because it complicates the message. But it's standard practice in diabetes education for lean patients, and it applies equally to GLP-1 injections.

When to use 45 degrees instead of 90:

• Body mass index under 22
• Injecting in the thigh or upper arm (thinner fat layer than abdomen)
• Visible muscle definition at the injection site
• History of injection-site pain suggesting muscle injection

When to stick with 90 degrees:

• Injecting in the abdomen with moderate to high body fat
• Using a 4 mm needle (short enough that 90 degrees is safe even at thin sites)
• Pinching the skin (which lifts fat away from muscle regardless of angle)

Injection-site reactions: what's normal, what's not

Normal reactions (common, self-limiting):

• Mild redness at the injection site, lasting 10 minutes to 2 hours. Caused by mechanical trauma from the needle or mild histamine release.
• Small bruise (ecchymosis), especially if you hit a capillary. More common in patients on aspirin or anticoagulants. Resolves in 3 to 7 days.
• Itching at the site for 30 minutes to 2 hours. Usually a mild immune response to the injection itself, not an allergy to the medication.
• Small lump (induration) at the site, lasting 12 to 48 hours. Caused by the volume of medication pooling in the tissue before it disperses. More common with larger doses (1 mg or higher).

In the SUSTAIN-1 trial (Sorli et al., Diabetes Care 2017), 12.4% of semaglutide patients reported injection-site reactions. Of those, 97% were mild (grade 1), and none required discontinuation of treatment.

Abnormal reactions (uncommon, warrant evaluation):

• Persistent lump lasting more than 7 days. Possible lipohypertrophy or, rarely, sterile abscess.
• Spreading redness (erythema) that expands over 24 to 48 hours. Possible cellulitis (skin infection).
• Warmth and tenderness at the site, especially if accompanied by fever. Possible infection.
• Hives (urticaria) beyond the immediate injection site. Possible allergic reaction.
• Severe pain during or after injection, out of proportion to a normal injection. Possible intramuscular injection or nerve contact.

If you develop spreading redness, warmth, or fever, contact your provider the same day. These symptoms can indicate bacterial contamination, which is rare but requires antibiotic treatment.

The FormBlends site-rotation protocol for compounded semaglutide

Compounded semaglutide in prefilled pens follows the same injection technique as brand-name Ozempic. Compounded semaglutide in vials requires drawing the dose with a syringe, which introduces an extra step but allows more precise dosing for custom titration schedules.

For vial-based compounded semaglutide:

1. Reconstitute the vial if you received lyophilized (freeze-dried) powder. Add the provided bacteriostatic water, swirl gently (don't shake), and let it sit for 5 minutes until fully dissolved. Mark the reconstitution date on the vial. Use within 28 days.

1. Draw the dose. Clean the vial's rubber stopper with an alcohol wipe. Draw air into the syringe equal to your dose volume. Insert the needle through the stopper, inject the air (this prevents a vacuum), then invert the vial and draw your dose. Tap the syringe to move air bubbles to the top, then push the plunger slightly to expel the air.

1. Inject using the same technique as the pen: subcutaneous, 90-degree angle (or 45 if lean), 6-second hold.

1. Dispose of the syringe in a sharps container. Unlike pen needles, syringes should never be reused, even for single-patient use.

The 12-zone rotation map we recommend:

Divide the abdomen into 4 quadrants (upper right, upper left, lower right, lower left, all at least 2 inches from the belly button). Divide each thigh into 4 zones (upper outer, upper front, mid outer, mid front). That's 12 zones total.

For weekly injections, rotate through all 12 zones over 12 weeks. Mark each injection on a body map (printable templates available in the FormBlends patient portal) or use a notes app. The pattern we see most consistently in patients who avoid lipohypertrophy: strict rotation plus a 1-inch minimum distance from the prior injection.

Patients who develop lumps almost always trace it to "I have a favorite spot that doesn't hurt as much." The spot that doesn't hurt is usually the spot you've already overused, where nerve endings have been damaged by repeated injections. The lack of pain is a warning sign, not a benefit.

Reusing needles: the false economy

Pen needles cost $15 to $40 for a box of 100, or roughly $0.15 to $0.40 per needle. Some patients reuse needles to save money. This is a false economy for three reasons:

1. Needles dull after one use. Electron microscopy studies show that even a single injection creates burrs and hooks on the needle tip. A dulled needle causes more tissue trauma, more pain, and higher bruising risk.

1. Reused needles increase infection risk. Even if you recap the needle and store it carefully, the needle is no longer sterile. Skin bacteria colonize the needle surface. A 2011 study in Mayo Clinic Proceedings (Puder et al.) cultured reused insulin pen needles and found bacterial growth in 31% of needles reused more than twice.

1. Reused needles clog. Semaglutide is viscous. After the first injection, a small amount of medication dries inside the needle bore, partially blocking it. The next injection requires more pressure to push the medication through, which increases the risk of incomplete dosing and pen malfunction.

The Novo Nordisk pen manual explicitly states: "Always use a new needle for each injection." This isn't upselling. It's engineering. The pen's dose accuracy specification assumes a new, unobstructed needle.

If cost is a barrier, ask your provider about patient assistance programs or switch to vial-based compounded semaglutide, where syringes cost about $0.10 each.

When to inject (morning vs evening, fasted vs fed)

Ozempic has a half-life of 7 days, which means the timing of your weekly injection has almost no effect on steady-state drug levels. You can inject in the morning, evening, fasted, or fed. The medication works the same.

That said, two timing considerations matter for comfort:

1. Nausea timing.

Nausea from semaglutide typically peaks 24 to 48 hours after injection, corresponding to the peak serum concentration. If you inject Friday evening, nausea is worst Sunday morning. If you inject Monday morning, nausea is worst Tuesday evening. Some patients prefer to schedule peak nausea for a weekend; others prefer a weekday when they're distracted by work.

2. Injection-site pain.

Injecting into a full stomach (after a meal) can make the abdominal injection site feel tighter and slightly more uncomfortable. Most patients report less injection-site discomfort when injecting fasted or at least 2 hours after eating.

The clinical trials didn't control for injection timing, so there's no published data comparing outcomes. The pattern we see in FormBlends patients: about 60% inject in the morning before breakfast, 30% inject in the evening before bed, and 10% inject at random times depending on schedule. All three groups report equivalent weight-loss outcomes.

Pick a consistent day and time that you'll remember. Consistency matters more than the specific hour.

Traveling with your pen: TSA rules and temperature control

TSA and air travel:

Ozempic pens and syringes are allowed in carry-on and checked baggage. You don't need a doctor's note for domestic U.S. flights, but carrying the prescription label or a provider's letter is smart for international travel. Pack the pen in your carry-on, not checked baggage, because checked baggage compartments can drop below freezing at altitude, which will ruin the medication.

TSA allows syringes and needles as long as they're accompanied by the medication in its original packaging. If you're carrying vial-based compounded semaglutide, bring the vial with the pharmacy label attached.

Temperature control:

Ozempic must be stored at 36°F to 46°F (2°C to 8°C) before first use. After first use, it can be kept at room temperature (up to 86°F / 30°C) for 56 days. If you're traveling for less than 8 weeks, you can leave the pen at room temperature in your luggage. For longer trips, or if you're traveling to hot climates, use a medication cooler with ice packs.

Don't freeze the pen. Frozen semaglutide loses potency and can't be used even after thawing. If the pen has been frozen (solid ice crystals visible in the cartridge), discard it.

For international travel across time zones, stick to your injection schedule based on your home time zone for the first week, then shift gradually (1 to 2 hours per day) to the new time zone if you're staying longer than 2 weeks. Because of semaglutide's long half-life, shifting your injection day by 12 to 24 hours has negligible effect on drug levels.

FAQ

How do you give yourself an Ozempic shot? Attach a new needle to the pen, select your dose, clean your injection site (abdomen or thigh) with alcohol, pinch the skin, insert the needle at a 90-degree angle, press the button, hold for 6 seconds, then withdraw and dispose of the needle. The full process takes about 60 seconds.

Where is the best place to inject Ozempic? The abdomen (at least 2 inches from the belly button) is the most common site because it has the thickest subcutaneous fat layer and the most consistent absorption. The front or outer thigh is the second-best option. Rotate sites weekly to prevent lipohypertrophy.

Does the Ozempic shot hurt? Most patients report minimal pain, comparable to a mosquito bite or less. Pain is more common if the medication is cold, if you inject too quickly, or if you reuse needles. Letting the pen reach room temperature and using a new needle each time reduces pain significantly.

How long do you hold the Ozempic pen in after injecting? Hold the pen in place for 6 seconds after pressing the dose button. This allows the full dose to flow into the tissue. Withdrawing early causes medication to leak out, reducing the effective dose by 6% to 12%.

Can you inject Ozempic in your arm? Yes, the upper arm (back, fatty area) is an FDA-approved injection site. Most patients find it difficult to reach and prefer the abdomen or thigh. If you use the arm, you'll likely need someone to help with the injection.

What happens if you inject Ozempic into muscle instead of fat? Intramuscular injection isn't dangerous but changes the absorption profile. The medication absorbs faster, which can increase nausea and reduce the duration of appetite suppression. To avoid muscle injection, pinch the skin or use a 45-degree angle if you're lean.

Do you need to pinch the skin when injecting Ozempic? Pinching is recommended for most patients because it lifts the subcutaneous fat away from the muscle, ensuring the needle lands in fat. If you have a higher body fat percentage and you're injecting in the abdomen, pinching may not be necessary.

Can you reuse Ozempic pen needles? No. Reusing needles increases infection risk, causes more pain (because the needle dulls), and can clog the needle with dried medication, leading to incomplete dosing. Always use a new needle for each injection.

What should you do if the Ozempic pen is leaking? If medication leaks from the pen before you inject, the cartridge may be cracked or the needle may not be attached tightly. Discard the pen and use a new one. If medication leaks from the injection site after you withdraw the needle, you didn't hold the pen in place long enough; count to 8 next time.

How do you know if you gave yourself the full Ozempic dose? After pressing the dose button and holding for 6 seconds, check the dose window. It should read "0." If it shows a number higher than 0, the full dose didn't deliver; contact your provider. If a drop of medication leaks from the injection site, you may have withdrawn too quickly.

Can you inject Ozempic cold, or does it need to be room temperature? You can inject it cold, but room-temperature medication causes less injection-site pain and flows more predictably through the needle. Remove the pen from the refrigerator 30 minutes before injection, or warm it in your hand for 10 minutes.

What's the difference between injecting Ozempic and compounded semaglutide? The injection technique is identical if the compounded semaglutide is in a prefilled pen. If it's in a vial, you'll need to draw the dose with a syringe, which adds one step (drawing the medication) but follows the same subcutaneous injection technique.

Sources

1. Sorli C et al. Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial. Lancet Diabetes Endocrinol. 2017.

1. Frid AH et al. New injection recommendations for patients with diabetes. Diabetes Metab. 2016.

1. Ignaut DA et al. Injection technique in patients with type 2 diabetes: a review of published data. Diabetes Ther. 2021.

1. Kapitza C et al. Pharmacokinetics of the long-acting GLP-1 analog dulaglutide in patients with type 2 diabetes: a comparison of subcutaneous versus intramuscular administration. Clin Pharmacokinet. 2018.

1. Puder JJ et al. Bacterial contamination of insulin pens in clinical practice. Mayo Clin Proc. 2011.

1. Marso SP et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes (SUSTAIN-6). N Engl J Med. 2016.

1. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021.

1. Davies M et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021.

1. Rubino D et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity (STEP 4). JAMA. 2021.

1. Garvey WT et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022.

1. Novo Nordisk. Ozempic (semaglutide) injection prescribing information. 2023.

1. American Diabetes Association. Insulin administration. Diabetes Care. 2022.

1. Frid A et al. Worldwide injection technique questionnaire study: population parameters and injection practices. Mayo Clin Proc. 2016.

1. Hirsch LJ et al. Comparative glycemic control, safety and patient ratings for a new 4 mm × 32G insulin pen needle in adults with diabetes. Curr Med Res Opin. 2010.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk.